期刊文献+

吸入M_3受体拮抗剂对稳定期COPD肺功能的影响 被引量:2

Effect of M_3 Receptor Antagonist on Lung Function in Stable COPD
原文传递
导出
摘要 目的:评价噻托溴铵干粉剂对中、重度稳定期慢性阻塞性肺疾病(COPD)患者肺功能的影响。方法:采用随机对照研究140例COPD患者,噻托溴铵组使用噻托溴铵干粉剂,对照组使用氨茶碱片,总观察时间12周,治疗前后测定肺功能。结果:治疗后噻托溴铵组深吸气量、第1秒用力肺活量和用力肺活量明显改善,分别增加了102mL,256mL和154mL,对照组改善不明显,仅分别增加了10mL,08mL,15mL。结论:噻托溴铵能改善中、重度稳定期COPD患者的肺功能,可提高患者的生活质量。 Objective:To research the effect of M3 receptor antagonist(tiotropium) on lung function in stably moderate and severe chronic obstructive pulmonary disease(COPD).Methods:A randomized controlled clinical trail was conducted in 140 patients with COPD.80 patients were treated by tiotropium(18μg,qd inhaled) and 60 patients were treated by placebo for aminophylline 12 weeks.Results:Tiotropium provided significantly improvement in inspiratory capacity(IC),forced expiratory volume in one second(FEV1) and forced vital capacity(FVC) than baseline,IC,FEV1 and FVC in tiotropium group was increased 102mL,256 mL and 154 mL respectively,and it was significantly higher than that aminophylline group(10 mL,08mL and 15 mL respectively).Conclusion:Tiotropium was an effective bronchodaliator on improving lung function and health status in patients with stably moderate and severe COPD.
出处 《现代生物医学进展》 CAS 2011年第3期505-507,共3页 Progress in Modern Biomedicine
基金 黑龙江省卫生厅资助项目(2006-212)
关键词 M3受体拮抗剂 慢性阻塞性肺疾病 肺功能 M3 receptor antagonist Chronic obstructive pulmonary disease Lung function
  • 相关文献

参考文献6

二级参考文献25

  • 1刘升明,王小平,王大礼,周玉民,吕嘉春,郑劲平,钟南山,冉丕鑫.广东部分地区慢性阻塞性肺疾病发病状况调查[J].中华医学杂志,2005,85(11):747-752. 被引量:150
  • 2Barnes PJ,Stockley RA.COPD:current therapeutic interventions and future approaches.Eur Respir J,2005,25:1084-1106.
  • 3Disse B,Reichl R,Speck G,et al.Ba 679 BR,a novel long-acting anticholinergic bronchodilator.Life Sci,1993,52:537-544.
  • 4Takahashi T,Belvisi MG,Patel H,et al.Effect of Ba 679 BR,a novel long-acting anticholinergic agent,on cholinergic neurotransmission in guinea pig and human airways.Am J Respir Crit Care Med,1994,150(6 Pt 1):1640-1645.
  • 52003 Update:Workshop Report,Global Strategy for Diagnosis,Management,and Prevention of COPD.National Heart,Lung,and Blood Institute and World Health Organization,Global initiative for chronic obstructive lung disease (GOLD).Available from:http://www.goldeopd.org/
  • 6Casaburi R,Mahler DA,Jones PW,et al.A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.Eur Respir J,2002,19:217-224.
  • 7Littner MR,Ilowite JS,Tashkin DP,et al.Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2000,161 (4 Pt 1):1136-1142.
  • 8Casaburi R,Briggs DD Jr,Donohue JF,et al.The spirometric efficacy of once-daily dosing with tiotropium in stable COPD:a 13-week multicenter trial.The US Tiotropium Study Group.Chest,2000,118:1294-1302.
  • 9O'Donnell DE,Fluge T,Gerken F,et al.Effects of tiotropium on lung hyperinflation,dyspnoea and exercise tolerance in COPD.Eur Respir J,2004,23:832-840.
  • 10Maltais F,Hamilton A,Marciniuk D,et al.Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.Chest,2005,128:1168-1178.

共引文献181

同被引文献29

  • 1柳涛,蔡柏蔷.一种新型的生活质量评估问卷:慢性阻塞性肺疾病评估测试[J].中国医学科学院学报,2010,32(2):234-238. 被引量:164
  • 2肖建,杜春玲.慢性阻塞性肺疾病病因及发病机制研究进展[J].中国老年学杂志,2014,34(11):3191-3194. 被引量:166
  • 3Rabe K F, Fabbri L M, Israel E, et al. Effect of ADRB2 polymorphisms on the efficacy of salmeterol andtiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial [J]. Lancet Respir Med, 2014, 2(1): 44-53.
  • 4Jenkins C R. Tiotropium and the risk of death in COPD [J]. NEnglJMed, 2014, 370(5): 482-483.
  • 5Kobli:ek V. The position of tiotropium in new treatment guidelines for chronic obstructive pulmonary disease [J]. VnitrLek, 2013, 59(12): 1073-1080.
  • 6Tashkin Donald P,Celli Bartolome,Senn Stephen,Burkhart Deborah,Kesten Steven,Menjoge Shailendra,Decramer Marc.A 4-year trial of tiotropium in chronic obstructive pulmonary disease. The New England Quarterly . 2008
  • 7Graeme P. Currie,Catherine Rossiter,Sean A. Miles,Daniel K.C. Lee,Owen J. Dempsey.Effects of tiotropium and other long acting bronchodilators in chronic obstructive pulmonary disease[J]. Pulmonary Pharmacology & Therapeutics . 2005 (2)
  • 8Jenkins C R.Tiotropium and the risk of death in COPD. The New England Journal of Medicine . 2014
  • 9Koblizek V.The position of tiotropium in new treatment guidelines for chronic obstructive pulmonary disease. Vnitrni Lekarstvi . 2013
  • 10曹登瑞,乔钦增,刘敏,刘涛,唐石铜,潘灵敏.杏根青龙汤对慢性阻塞性肺疾病患者气道炎症及气道重塑的影响[J].临床肺科杂志,2011,16(1):43-44. 被引量:3

引证文献2

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部